H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the "Food and Drug Administration Safety Over Sequestration Act."
H.R. 160, the"Protect Medical Innovation Act.
S. 149, the "Medical Device Access and Innovation Protection Act."
S. 1077, the "Advancing Breakthrough Devices for Patients Act."
S. 1622, the "FDA Device Accountability Act."
S. 2737, the "Improving Medical Device Innovation Act."
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
H.R. 2146, the "Trade Preferences Extension Act."
Policy issues relating to the Trans-Pacific Partnership trade agreement.
Duration: June 1, 2009
to
May 31, 2016
General Issues: Health Issues , Taxation/Internal Revenue Code , Trade (Domestic & Foreign) , Medicare/Medicaid , Budget/Appropriations , Manufacturing , Transportation
Spending: about $920,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Chris Jones Chief of Staff/Rep. Mike Ferguson
Deputy Chief of Staff/Rep. David McIntosh
Communications Dir./House Government Reform Subcommittee
Press Secretary/Rep. John Myers
Deputy Chief of Staff/Rep. Dvid McIntosh
Communications Dir./House Govt. Reform Subcmt
Communications Dir/House Govt Reform Subcmte
Adam Higgins Legislative Asst./Rep. Mike Ferguson
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2016
Ferguson Strategies, LLC terminated an engagement in which they represented C.R. Bard Inc. on July 19, 2016.
Original Filing: 300813714.xml
Lobbying Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the "Food and Drug Administration Safety Over Sequestration Act."
H.R. 160, the"Protect Medical Innovation Act.
S. 149, the "Medical Device Access and Innovation Protection Act."
S. 1077, the "Advancing Breakthrough Devices for Patients Act."
S. 1622, the "FDA Device Accountability Act."
S. 2737, the "Improving Medical Device Innovation Act."
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2146, the "Trade Preferences Extension Act."
Policy issues relating to the Trans-Pacific Partnership trade agreement.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2016
In Q1, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 19, 2016.
Original Filing: 300794953.xml
Lobbying Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 160, the Protect Medical Innovation Act.
S. 149, the Medical Device Access and Innovation Protection Act.
S. 1077, the "Advancing Breakthrough Devices for Patients Act."
S. 1622, the "FDA Device Accountability Act."
S. 2737, the "Improving Medical Device Innovation Act."
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2146, the "Trade Preferences Extension Act."
Policy issues relating to the Trans-Pacific Partnership trade agreement.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2015
In Q4, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 15, 2016.
Original Filing: 300772683.xml
Lobbying Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection Act.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2020, the "Protecting Americans from Tax Hikes Act," specifically that section suspending the medical device excise tax.
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2146, the "Trade Preferences Extension Act."
Policy issues relating to the Trans-Pacific Partnership trade agreement.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2015
In Q3, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Oct. 19, 2015.
Original Filing: 300758288.xml
Lobbying Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection Act.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2146, the "Trade Preferences Extension Act."
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2015
In Q2, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 17, 2015.
Original Filing: 300738638.xml
Lobbying Issues
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection Act.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160, the Protect Medical Innovation Act.
S.149, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2146, the "Trade Preferences Extension Act."
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2015
In Q1, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 20, 2015.
Original Filing: 300726381.xml
Lobbying Issues
21st Century Cures draft legislation, specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
H.R. 1078, the Food and Drug Administration Safety Over Sequestration Act.
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection Act.
H.R. 2, the Medicare Access and CHIP Reauthorization Act.
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection Act.
H.R. 880, the American Research and Competitiveness Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Trade Promotion Authority relating to the Trans-Pacific Partnership and the Transatlantic Trade and Investment Partnership, specifically issues relating to transparency and procedural fairness in reimbursement decisions, price controls and trade secrets with respect to medical technology manufacturers.
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2014
In Q4, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 20, 2015.
Original Filing: 300702897.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically those sections relating to implementation of the medical device tax and the Sunshine Act.
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act."
S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
Policy issues relating to the Final 2014 Medicare Hospital Outpatient Prospective Payment System Rule.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law No. 113-295, the "Tax Increase Prevention Act."
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act."
H.R. 4438, the "American Research and Competitiveness Act."
H.R. 3474, the "Hire More Heroes Act" (as amended by the Senate).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2014
In Q3, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Oct. 14, 2014.
Original Filing: 300676068.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically those sections relating to implementation of the medical device tax and the Sunshine Act.
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act."
S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
Policy issues relating to the Final 2014 Medicare Hospital Outpatient Prospective Payment System Rule.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act"
S.232, the "Medical Device Access and Innovation Protection Act"
H.R. 4438, the "American Research and Competitiveness Act"
H.R. 3474, the "Hire More Heroes Act" (as amended by the Senate)
S. 2260, the "Expiring Provisions Improvement, Reform and Efficiency Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 16, 2014.
Original Filing: 300657543.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Medical Device User Fee program.
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," specifically those sections relating to implementation of the medical device tax and the Sunshine Act.
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act."
S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act."
H.R. 4438, the "American Research and Competitiveness Act."
H.R. 3474, the "Hire More Heroes Act" (as amended by the Senate).
S. 2260, the "Expiring Provisions Improvement, Reform and Efficiency Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 2925, the "Strengthening Medicare Anti-Fraud Measures Act."
Policy issues relating to the Final 2014 Medicare Hospital Outpatient Prospective Payment System Rule.
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, Ferguson Strategies, LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 19, 2014.
Original Filing: 300642821.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Medical Device User Fee program, and policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act," and S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Final 2014 Medicare Hospital Outpatient Prospective Payment System Rule.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 15, 2014.
Original Filing: 300614882.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Medical Device User Fee program, and policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act," and S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Oct. 17, 2013.
Original Filing: 300596531.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Medical Device User Fee program, and policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
H.R. 351, "Protecting Seniors' Access to Medicare Act," and S. 351, "Protecting Seniors' Access to Medicare Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 17, 2013.
Original Filing: 300573960.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Medical Device User Fee program.
Policy and implementation issues relating to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act," including S.Amdt. 297 to S.Con.Res. 8.
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 19, 2013.
Original Filing: 300556384.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the Medical Device User Fee program.
Policy and implementation issues related to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 523, the "Protect Medical Innovation Act."
S.232, the "Medical Device Access and Innovation Protection Act," including S.Amdt. 297 to S.Con.Res. 8.
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.CON.RES.8, FY 2014 budget resolution.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 17, 2013.
Original Filing: 300532342.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the Medical Device User Fee program.
Policy and implementation issues related to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act," including Accountable Care Organizations, the Independent Payment Advisory Board, and comparative effectiveness research.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 436, the "Protect Medical Innovation Act."
S.17, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of Public Law No. 111-203, the "Wall Street Reform and Consumer Protection Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.J. Res.117, "Continuing Appropriations Resolution, Fiscal Year 2013," specifically those sections relating to appropriations for the Food and Drug Admnistration's Center for Devices and Radiological Health.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Oct. 19, 2012.
Original Filing: 300512130.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the Medical Device User Fee program.
Policy and implementation issues related to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act," including Accountable Care Organizations, the Independent Payment Advisory Board, and comparative effectiveness research.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 436, the "Protect Medical Innovation Act."
S.17, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of Public Law No. 111-203, the "Wall Street Reform and Consumer Protection Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.J. Res.117, "Continuing Appropriations Resolution, 2013," specifically those sections relating to appropriations for the Food and Drug Admnistration's Center for Devices and Radiological Health.
H.R. 5973 and S. 2375, the "FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act," specifically those sections relating to appropriations for FDA's CDRH.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 19, 2012.
Original Filing: 300491042.xml
Lobbying Issues
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the Medical Device User Fee program.
Policy and implementation issues related to Public Law No. 111-148, the "Patiet Protection and Affordable Care Act," including Accountable Care Organizations, the Independent Payment Advisory Board, and comparative effectiveness research.H.R. 3209, Premarket Predictability Act.
H.R. 3208, Patients Come First Act.
H.R. 3214/S. 1972, Food and Drug Administration Mission Reform Act.
H.R. 3230, Keeping America Competitive through Harmonization Act.
H.R. 3847, Safety of Untested and New Devices Act.
S. 1700, Medical Device Regulatory Improvement Act.
S. 1865, Patient Access to Medical Innovation Act.
S. 1995, Medical Device Patient Safety Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 436, the "Protect Medical Innovation Act."
S.17, the "Medical Device Access and Innovation Protection Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of Public Law No. 111-203, the "Wall Street Reform and Consumer Protection Act."
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5973 and S. 2375, the "FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act," specifically those provisions related to appropriations for the Food and Drug Admnistration's Center for Devices and Radiological Health.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 17, 2012.
Original Filing: 300462196.xml
Lobbying Issues
Policy issues relating to Patient Protection and Affordable Care Act (Public Law 111-148) implementation, including the medical device tax (S. 17 and H.R. 436); Accountable Care Organizations; the Independent Payment Advisory Board (H.R. 452); and comparative effectiveness research. Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act.H.R. 3209, Premarket Predictability Act.
H.R. 3208, Patients Come First Act.
H.R. 3214/S. 1972, Food and Drug Administration Mission Reform Act.
H.R. 3230, Keeping America Competitive through Harmonization Act.
H.R. 3847, Safety of Untested and New Devices Act.
S. 1700, Medical Device Regulatory Improvement Act.
S. 1865, Patient Access to Medical Innovation Act.
S. 1995, Medical Device Patient Safety Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.17, the "Medical Device Access and Innovation Protection Act."
H.R. 436, the "Protect Medical Innovation Act."
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Proposed Department of Transportation regulation regarding the air-shipment of products containing lithium batteries.
H.R. 658, the "FAA Reauthorization and Reform Act."
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of the Wall Street Reform and Consumer Protection Act (Public Law 111-203).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 17, 2012.
Original Filing: 300438596.xml
Lobbying Issues
Policy issues relating to Patient Protection and Affordable Care Act (Public Law 111-148) implementation, including the medical device tax (S. 17 and H.R. 436); Accountable Care Organizations; the Independent Payment Advisory Board (H.R. 452); and comparative effectiveness research. Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.17, the Medical Device Access and Innovation Protection Act.
H.R. 436, the Protect Medical Innovation Act.
Reauthorization of the federal research and development tax credit.
Policy issues relating to corporate tax reform.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Policy issues relating to the Centers for Medicare and Medicaid Services' Healthcare Common Procedure Coding System.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Proposed Department of Transportation regulation regarding the air-shipment of products containing lithium batteries.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Policy issues related to proposed Securities and Exchange Commission regulations regarding implementation of Section 1502 of the Wall Street Reform and Consumer Protection Act (Public Law 111-203).
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Oct. 18, 2011.
Original Filing: 300418700.xml
Lobbying Issues
Policy issues related to Patient Protection and Affordable Care Act implementation, including the medical device tax (S. 17 and H.R. 436); Accountable Care Organizations; and the Independent Payment Advisory Board (H.R. 452). Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.17, the Medical Device Access and Innovation Protection Act.
H.R. 436, the Protect Medical Innovation Act.
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2011
In Q2, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 19, 2011.
Original Filing: 300397280.xml
Lobbying Issues
Policy issues related to Patient Protection and Affordable Care Act implementation, including the medical device tax (S. 17, S. 262 and H.R. 436); Accountable Care Organizations; and the Independent Payment Advisory Board (H.R. 452). Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2011
In Q1, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 18, 2011.
Original Filing: 300367484.xml
Lobbying Issues
Policy issues related to Patient Protection and Affordable Care Act implementation, including the medical device tax (S. 17, S. 262 and H.R. 436); Accountable Care Organizations; and the Independent Payment Advisory Board (H.R. 452). Also, policy issues related to the FDA's 510(k) regulatory proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $50,000. The report was filed on Jan. 17, 2011.
Original Filing: 300339479.xml
Lobbying Issues
Policy issues related to Patient Protection and Affordable Care Act implementation, including the medical device tax, Accountable Care Organizations, and the Independent Payment Advisory Board. Also, policy issues related to the FDA's 510(k) regulatory proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2010
In Q3, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $50,000. The report was filed on Oct. 13, 2010.
Original Filing: 300311539.xml
Lobbying Issues
Policy issues relating to health care reform implementation, including the medical device tax.
FDA 510(k) proposals.
Medical Device Safety Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2010
In Q2, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on July 16, 2010.
Original Filing: 300288404.xml
Lobbying Issues
Health care reform legislation, including the medical device tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on April 19, 2010.
Original Filing: 300264893.xml
Lobbying Issues
Health care reform legislation, including the medical device tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $30,000. The report was filed on Jan. 19, 2010.
Original Filing: 300236955.xml
Lobbying Issues
Health care reform legislation, including the medical device tax.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Reauthorization of the federal research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $50,000. The report was filed on Oct. 20, 2009.
Original Filing: 300219035.xml
Lobbying Issues
Health care policy issues; health care regulatory issues; and health care reform legislation.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Ferguson Strategies LLC lobbied for C.R. Bard Inc. , earning $20,000. The report was filed on July 17, 2009.
Original Filing: 300183854.xml
Lobbying Issues
Health care policy issues; health care regulatory issues; and health care reform legislation.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
Ferguson Strategies LLC filed a lobbying registration on July 7, 2009 to represent C.R. Bard Inc., effective June 1, 2009.
Original Filing: 300173662.xml
Issue(s) they said they’d lobby about: Health care reform legislation.
Medical Device Safety Act.
Research and development tax credit, and tax deferral legislation. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...